172 related articles for article (PubMed ID: 132848)
1. Generation of kinin by plasma kallikrein and plasmin and the effect of alpha1-antitrypsin and antithrombin III on the kinongenases.
Habal FM; Burrowes CE; Movat HZ
Adv Exp Med Biol; 1976; 70(00):23-36. PubMed ID: 132848
[No Abstract] [Full Text] [Related]
2. Activation of human Glu-plasminogen to Glu-plasmin by urokinase in presence of plasmin inhibitors. Streptomyces leupeptin and human plasma alpha1-antitrypsin and antithrombin III (plus heparin).
Summaria L; Boreisha IG; Arzadon L; Robbins KC
J Biol Chem; 1977 Jun; 252(11):3945-51. PubMed ID: 140876
[No Abstract] [Full Text] [Related]
3. Interaction of leukocytes and endotoxin with the plasmin and kinin systems.
Miller RL; Webster ME; Melmon KL
Eur J Pharmacol; 1975 Aug; 33(1):53-60. PubMed ID: 126170
[TBL] [Abstract][Full Text] [Related]
4. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
Kaplan AP; Meier HL; Mandle R
Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
[No Abstract] [Full Text] [Related]
5. Alpha 1-antitrypsin and alpha 2-macroglobulin do not inhibit the kinin-releasing activity of kallikreins from human urine and saliva.
Sakamoto W; Nishikaze O
Biochim Biophys Acta; 1980 Dec; 633(3):305-9. PubMed ID: 6163451
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
[TBL] [Abstract][Full Text] [Related]
7. Surface activation of blood coagulation, fibrinolysis and kinin formation.
Heimark RL; Kurachi K; Fujikawa K; Davie EW
Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
[TBL] [Abstract][Full Text] [Related]
8. Mouse plasma trypsin inhibitors: inhibitory spectrum of contrapsin and alpha-1-antitrypsin.
Takahara H; Sinohara H
Thromb Res; 1982 Jul; 27(1):45-50. PubMed ID: 6214866
[TBL] [Abstract][Full Text] [Related]
9. The antithrombin activity of alpha-1-protease inhibitor: the antitrypsin activity of antithrombin III.
Learned LA; Bloom JW; Hunter MJ
Thromb Res; 1976 Jan; 8(1):99-109. PubMed ID: 1082656
[No Abstract] [Full Text] [Related]
10. Actions of urinary kallikrein, plasmin, and other kininogenases on bovine plasma high-molecular-weight kininogen.
Han YN; Kato H; Iwanaga S; Komiya M
J Biochem; 1978 Jan; 83(1):223-35. PubMed ID: 146707
[No Abstract] [Full Text] [Related]
11. Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis.
Cassim B; Shaw OM; Mazur M; Misso NL; Naran A; Langlands DR; Thompson PJ; Bhoola KD
Rheumatology (Oxford); 2009 May; 48(5):490-6. PubMed ID: 19254919
[TBL] [Abstract][Full Text] [Related]
12. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
[TBL] [Abstract][Full Text] [Related]
13. [Biochemistry of the kallikrein-kinin system].
Kato H; Fujii S
Nihon Rinsho; 1978 Aug; 36(8):2865-72. PubMed ID: 152362
[No Abstract] [Full Text] [Related]
14. The kinin system: its relation to blood coagulation, fibrinolysis and the formed elements of the blood.
Movat HZ
Rev Physiol Biochem Pharmacol; 1978; 84():143-202. PubMed ID: 152965
[No Abstract] [Full Text] [Related]
15. Characterization of human salivary kallikrein: reactivities to human plasma kininogens and proteinase inhibitors.
Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O
J Biochem; 1983 Mar; 93(3):833-8. PubMed ID: 6553577
[TBL] [Abstract][Full Text] [Related]
16. [The effect of plasmin on the kinin system of rat blood].
Andreenko GV; Suvorov AV
Nauchnye Doki Vyss Shkoly Biol Nauki; 1975; (4):44-8. PubMed ID: 130169
[No Abstract] [Full Text] [Related]
17. [The kinin and plasmin systems of the blood serum and cerebro- spinal fluid in patients with multiple sclerosis and schizophrenia].
Vilkov GA; Martirosian VV; Trapezontseva RA; Kozlova LS; Ellanskiĭ IuIu
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):23-7. PubMed ID: 2477972
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
Sumi H; Takada Y; Takada A
Nihon Seirigaku Zasshi; 1977; 39(5):112-4. PubMed ID: 72149
[No Abstract] [Full Text] [Related]
19. Expression and characterization of human tissue kallikrein variants.
Chan H; Springman EB; Clark JM
Protein Expr Purif; 1998 Apr; 12(3):361-70. PubMed ID: 9535704
[TBL] [Abstract][Full Text] [Related]
20. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue.
Maier-Hauff K; Baethmann AJ; Lange M; Schürer L; Unterberg A
J Neurosurg; 1984 Jul; 61(1):97-106. PubMed ID: 6563063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
